{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T02:30:38Z","timestamp":1786415438002,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"DOI":"10.1007\/s00428-026-04673-1","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T02:06:07Z","timestamp":1786413967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MNDA-positive Follicular Lymphoma is a heterogeneous disease: a case series study of 19 patients"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1242-6669","authenticated-orcid":false,"given":"Marcos","family":"Rebollo-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7070-0550","authenticated-orcid":false,"given":"Francisco Javier D\u00edaz","family":"de la Pinta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5450-4146","authenticated-orcid":false,"given":"Rebeca","family":"Manso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3957-3618","authenticated-orcid":false,"given":"Daniel","family":"Morillo-Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9807-2875","authenticated-orcid":false,"given":"Giovanna","family":"Roncador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8543-6767","authenticated-orcid":false,"given":"Marta","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2191-1327","authenticated-orcid":false,"given":"Socorro Mar\u00eda","family":"Rodr\u00edguez-Pinilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"4673_CR1","doi-asserted-by":"publisher","unstructured":"Carbone A, Roulland S, Gloghini A, Younes A, von Keudell G, L\u00f3pez-Guillermo A et al (2019) Follicular lymphoma. Nat Reviews Disease Primers 5. https:\/\/doi.org\/10.1038\/s41572-019-0132-x","DOI":"10.1038\/s41572-019-0132-x"},{"key":"4673_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4132\/jptm.2021.09.29","volume":"56","author":"M Khanlari","year":"2022","unstructured":"Khanlari M, Chapman JR (2022) Follicular lymphoma: updates for pathologists. J Pathol Translational Med 56:1\u201315. https:\/\/doi.org\/10.4132\/jptm.2021.09.29","journal-title":"J Pathol Translational Med"},{"key":"4673_CR3","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IB, de Berti O (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36:1720\u20131748. https:\/\/doi.org\/10.1038\/s41375-022-01620-2","journal-title":"Leukemia"},{"key":"4673_CR4","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1080\/17474086.2020.1850252","volume":"13","author":"R Alonso-Alonso","year":"2020","unstructured":"Alonso-Alonso R, Rodriguez M, Morillo D, Cordoba R, Piris MA (2020) An analysis of genetic targets for guiding clinical management of follicular lymphoma. Expert Rev Hematol 13:1361\u20131372. https:\/\/doi.org\/10.1080\/17474086.2020.1850252","journal-title":"Expert Rev Hematol"},{"key":"4673_CR5","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1002\/ajh.26737","volume":"97","author":"E Jacobsen","year":"2022","unstructured":"Jacobsen E (2022) Follicular lymphoma: 2023 update on diagnosis and management. Am J Hematol 97:1638\u20131651. https:\/\/doi.org\/10.1002\/ajh.26737","journal-title":"Am J Hematol"},{"key":"4673_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3960\/jslrt.23014","volume":"63","author":"J Carreras","year":"2023","unstructured":"Carreras J (2023) The pathobiology of follicular lymphoma. J Clin Experimental Hematopathology 63:152\u2013163. https:\/\/doi.org\/10.3960\/jslrt.23014","journal-title":"J Clin Experimental Hematopathology"},{"key":"4673_CR7","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.1182\/bloodadvances.2020002944","volume":"4","author":"D Nann","year":"2020","unstructured":"Nann D, Ramis-Zaldivar JE, M\u00fcller I, Gonzalez-Farre B, Schmidt J, Egan C et al (2020) Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease. Blood Adv 4:5652\u20135665. https:\/\/doi.org\/10.1182\/bloodadvances.2020002944","journal-title":"Blood Adv"},{"key":"4673_CR8","doi-asserted-by":"publisher","first-page":"5258","DOI":"10.1182\/bloodadvances.2022009456","volume":"7","author":"I Salaverria","year":"2023","unstructured":"Salaverria I, Weigert O, Quintanilla-Martinez L (2023) The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas. Blood Adv 7:5258\u20135271. https:\/\/doi.org\/10.1182\/bloodadvances.2022009456","journal-title":"Blood Adv"},{"key":"4673_CR9","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","volume":"133","author":"R Willemze","year":"2019","unstructured":"Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH et al (2019) The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood 133:1703\u20131714. https:\/\/doi.org\/10.1182\/blood-2018-11-881268","journal-title":"Blood"},{"key":"4673_CR10","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC et al (2022) The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood 140:1229\u20131253. https:\/\/doi.org\/10.1182\/blood.2022015851","journal-title":"Blood"},{"key":"4673_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/modpathol.2009.146","volume":"23","author":"JF Gradowski","year":"2010","unstructured":"Gradowski JF, Jaffe ES, Warnke RA, Pittaluga S, Surti U, Gole LA et al (2010) Follicular lymphomas with plasmacytic differentiation include two subtypes. Mod Pathol 23:71\u201379. https:\/\/doi.org\/10.1038\/modpathol.2009.146","journal-title":"Mod Pathol"},{"key":"4673_CR12","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1046\/j.1365-2559.2003.01580.x","volume":"42","author":"JR Goodlad","year":"2003","unstructured":"Goodlad JR, Batstone PJ, Hamilton D, Hollowood K (2003) Follicular lymphoma with marginal zone differentiation: cytogenetic findings in support of a high-risk variant of follicular lymphoma. Histopathology 42:292\u2013298. https:\/\/doi.org\/10.1046\/j.1365-2559.2003.01580.x","journal-title":"Histopathology"},{"key":"4673_CR13","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1038\/leu.2009.108","volume":"23","author":"G Kanellis","year":"2009","unstructured":"Kanellis G, Roncador G, Arribas A, Mollejo M, Montes-Moreno S, Maestre L et al (2009) Identification of MNDA as a new marker for nodal marginal zone lymphoma. Leukemia 23:1847\u20131857. https:\/\/doi.org\/10.1038\/leu.2009.108","journal-title":"Leukemia"},{"key":"4673_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/PAI.0000000000001115","volume":"31","author":"N Gupta","year":"2023","unstructured":"Gupta N, Roychoudry S, Sticco KL, Hsu P, Zhang X, Sheikh-Fayyaz S (2023) Study of the Utility of Myeloid Cell Nuclear Differentiation Antigen (MNDA) in the Diagnosis of Marginal Zone Lymphoma. Appl Immunohistochem Mol Morphology 31:217\u2013223. https:\/\/doi.org\/10.1097\/PAI.0000000000001115","journal-title":"Appl Immunohistochem Mol Morphology"},{"key":"4673_CR15","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.3324\/haematol.2014.120956","volume":"100","author":"M van den Brand","year":"2015","unstructured":"van den Brand M, Mathijssen JJM, Garcia-Garcia M, Hebeda KM, Groenen PJTA, Falini B et al (2015) Immunohistochemical differentiation between follicular lymphoma and nodal marginal zone lymphoma\u2013combined performance of multiple markers. Haematologica 100:e358\u2013360. https:\/\/doi.org\/10.3324\/haematol.2014.120956","journal-title":"Haematologica"},{"key":"4673_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00428-022-03432-2","volume":"482","author":"C Laurent","year":"2023","unstructured":"Laurent C, Cook JR, Yoshino T, Quintanilla-Martinez L, Jaffe ES (2023) Follicular lymphoma and marginal zone lymphoma: how many diseases? Virchows Arch 482:149\u2013162. https:\/\/doi.org\/10.1007\/s00428-022-03432-2","journal-title":"Virchows Arch"},{"key":"4673_CR17","doi-asserted-by":"publisher","unstructured":"Zhang L-F, Shui R-H, Lu H-F, Jiang W-H, Cai X, Li X-Q et al (2024) MNDA expression and its value in differential diagnosis of B-cell non-Hodgkin lymphomas: a comprehensive analysis of a large series of 1293 cases. Diagn Pathol 19. https:\/\/doi.org\/10.1186\/s13000-024-01481-6","DOI":"10.1186\/s13000-024-01481-6"},{"key":"4673_CR18","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E et al (2014) Recommendations for initial evaluation, staging, and response assessment of hodgkin and non-hodgkin lymphoma: The lugano classification. J Clin Oncol 32:3059\u20133067. https:\/\/doi.org\/10.1200\/JCO.2013.54.8800","journal-title":"J Clin Oncol"},{"key":"4673_CR19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/ajcp\/aqx099","volume":"148","author":"CA Kunder","year":"2017","unstructured":"Kunder CA, Roncador G, Advani RH, Gualco G, Bacchi CE, Sabile JM et al (2017) KLHL6 Is Preferentially Expressed in Germinal Center-Derived B-Cell Lymphomas. Am J Clin Pathol 148:465\u2013476. https:\/\/doi.org\/10.1093\/ajcp\/aqx099","journal-title":"Am J Clin Pathol"},{"key":"4673_CR20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1182\/blood-2007-06-094151","volume":"111","author":"S Montes-Moreno","year":"2008","unstructured":"Montes-Moreno S, Roncador G, Maestre L, Mart\u00ednez N, Sanchez-Verde L, Camacho FI et al (2008) Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas. Blood 111:351\u2013358. https:\/\/doi.org\/10.1182\/blood-2007-06-094151","journal-title":"Blood"},{"key":"4673_CR21","doi-asserted-by":"publisher","first-page":"16124","DOI":"10.18632\/oncotarget.24592","volume":"9","author":"R Manso","year":"2018","unstructured":"Manso R, Gonz\u00e1lez-Rinc\u00f3n J, Rodr\u00edguez-Justo M, Roncador G, G\u00f3mez S, S\u00e1nchez-Beato M et al (2018) Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features. Oncotarget 9:16124\u201316133. https:\/\/doi.org\/10.18632\/oncotarget.24592","journal-title":"Oncotarget"},{"key":"4673_CR22","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1182\/blood.V99.10.3806","volume":"99","author":"G Ott","year":"2002","unstructured":"Ott G, Katzenberger T, Lohr A, Kindelberger S, R\u00fcdiger T, Wilhelm M et al (2002) Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood 99:3806\u20133812. https:\/\/doi.org\/10.1182\/blood.V99.10.3806","journal-title":"Blood"},{"key":"4673_CR23","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.1182\/bloodadvances.2022009467","volume":"7","author":"WR Burack","year":"2023","unstructured":"Burack WR, Li H, Adlowitz D, Spence JM, Rimsza LM, Shadman M et al (2023) Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma. Blood Adv 7:5082\u20135090. https:\/\/doi.org\/10.1182\/bloodadvances.2022009467","journal-title":"Blood Adv"},{"key":"4673_CR24","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1182\/blood-2008-05-154013","volume":"112","author":"D O\u2019Shea","year":"2008","unstructured":"O\u2019Shea D, O\u2019Riain C, Taylor C, Waters R, Carlotti E, MacDougall F et al (2008) The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival. Blood 112:3126\u20133129. https:\/\/doi.org\/10.1182\/blood-2008-05-154013","journal-title":"Blood"},{"key":"4673_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3960\/jslrt.53.49","volume":"53","author":"L Abd Al-Kader","year":"2013","unstructured":"Abd Al-Kader L, Sato Y, Takata K, Ohshima K-I, Sogabe Y, Fujii K et al (2013) A case of conjunctival follicular lymphoma mimicking mucosa-associated lymphoid tissue lymphoma. J Clin Exp Hematop 53:49\u201352. https:\/\/doi.org\/10.3960\/jslrt.53.49","journal-title":"J Clin Exp Hematop"},{"key":"4673_CR26","doi-asserted-by":"publisher","first-page":"5328","DOI":"10.1182\/blood-2025-5328","volume":"146","author":"J Krull","year":"2025","unstructured":"Krull J, Ma Q, Contreras Guzman E, King R, Feldman A, Dasari S et al (2025) Bioflipi scores define distinct immune profiles in follicular lymphoma. Blood 146:5328. https:\/\/doi.org\/10.1182\/blood-2025-5328","journal-title":"Blood"},{"key":"4673_CR27","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1182\/blood-2023-180106","volume":"142","author":"J Han","year":"2023","unstructured":"Han J, McCall CM, Isom S, Smith W, Jenneman D, Begley S et al (2023) High Ki67 Index Is Associated with Shorter Progression Free Survival in Follicular Lymphoma Patients Treated with Frontline Immunochemotherapy. Blood 142:4385\u20134385. https:\/\/doi.org\/10.1182\/blood-2023-180106","journal-title":"Blood"},{"key":"4673_CR28","first-page":"3366","volume":"11","author":"Y Kawaguchi","year":"2018","unstructured":"Kawaguchi Y, Shiozawa E, Shimada S, Sasaki Y, Abe M, Murai S et al (2018) Ki-67 expression of immunohistochemistry using computerized image analysis is a useful prognostic marker in follicular lymphomas. Int J Clin Exp Pathol 11:3366\u20133374","journal-title":"Int J Clin Exp Pathol"},{"key":"4673_CR29","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1038\/s41375-019-0691-6","volume":"34","author":"F Cucco","year":"2020","unstructured":"Cucco F, Barrans S, Sha C, Clipson A, Crouch S, Dobson R et al (2020) Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC\/BCL2 double-hit. Leukemia 34:1329\u20131341. https:\/\/doi.org\/10.1038\/s41375-019-0691-6","journal-title":"Leukemia"},{"key":"4673_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.humpath.2021.04.014","volume":"114","author":"S Chaudhary","year":"2021","unstructured":"Chaudhary S, Brown N, Song JY, Yang L, Skrabek P, Nasr MR et al (2021) Relative frequency and clinicopathologic characteristics of MYC-rearranged follicular lymphoma. Hum Pathol 114:19\u201327. https:\/\/doi.org\/10.1016\/j.humpath.2021.04.014","journal-title":"Hum Pathol"},{"key":"4673_CR31","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1182\/blood-2016-02-696757","volume":"128","author":"V Spina","year":"2016","unstructured":"Spina V, Khiabanian H, Messina M, Monti S, Cascione L, Bruscaggin A et al (2016) The genetics of nodal marginal zone lymphoma. Blood 128:1362\u20131373. https:\/\/doi.org\/10.1182\/blood-2016-02-696757","journal-title":"Blood"},{"key":"4673_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.beha.2016.11.001","volume":"30","author":"S Pileri","year":"2017","unstructured":"Pileri S, Ponzoni M (2017) Pathology of nodal marginal zone lymphomas. Best Pract Res Clin Haematol 30:50\u201355. https:\/\/doi.org\/10.1016\/j.beha.2016.11.001","journal-title":"Best Pract Res Clin Haematol"},{"key":"4673_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1309\/AJCPZQ1GXBBNG8OG","volume":"132","author":"ME Salama","year":"2009","unstructured":"Salama ME, Lossos IS, Warnke RA, Natkunam Y (2009) Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: a study of 51 cases. Am J Clin Pathol 132:39\u201349. https:\/\/doi.org\/10.1309\/AJCPZQ1GXBBNG8OG","journal-title":"Am J Clin Pathol"},{"key":"4673_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1309\/AJCPHPVH4M7MTWUN","volume":"140","author":"KS Dyhdalo","year":"2013","unstructured":"Dyhdalo KS, Lanigan C, Tubbs RR, Cook JR (2013) Immunoarchitectural patterns of germinal center antigens including LMO2 assist in the differential diagnosis of marginal zone lymphoma vs follicular lymphoma. Am J Clin Pathol 140:149\u2013154. https:\/\/doi.org\/10.1309\/AJCPHPVH4M7MTWUN","journal-title":"Am J Clin Pathol"},{"key":"4673_CR35","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/modpathol.3880518","volume":"15","author":"A-I S\u00e1ez","year":"2002","unstructured":"S\u00e1ez A-I, Artiga M-J, S\u00e1nchez-Beato M, S\u00e1nchez-Verde L, Garc\u00eda J-F, Camacho F-I et al (2002) Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1\/OBF.1 in lymphomas. Mod Pathol 15:211\u2013220. https:\/\/doi.org\/10.1038\/modpathol.3880518","journal-title":"Mod Pathol"},{"key":"4673_CR36","doi-asserted-by":"publisher","first-page":"103786","DOI":"10.1016\/j.amsu.2022.103786","volume":"78","author":"S Ismail","year":"2022","unstructured":"Ismail S, Elshimali Y, Daoud A, Alshehabi Z (2022) Immunohistochemical expression of transcription factors PAX5, OCT2, BCL6 and transcription regulator P53 in Non-Hodgkin lymphomas: A diagnostic cross-sectional study. Ann Med Surg (Lond) 78:103786. https:\/\/doi.org\/10.1016\/j.amsu.2022.103786","journal-title":"Ann Med Surg (Lond)"},{"key":"4673_CR37","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1182\/blood.2020010175","volume":"137","author":"S Song","year":"2021","unstructured":"Song S, Cao C, Choukrallah M-A, Tang F, Christofori G, Kohler H et al (2021) OBF1 and Oct factors control the germinal center transcriptional program. Blood 137:2920\u20132934. https:\/\/doi.org\/10.1182\/blood.2020010175","journal-title":"Blood"},{"key":"4673_CR38","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1182\/blood-2006-08-039024","volume":"109","author":"Y Natkunam","year":"2006","unstructured":"Natkunam Y, Zhao S, Mason DY, Chen J, Taidi B, Jones M et al (2006) The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. Blood 109:1636\u20131642. https:\/\/doi.org\/10.1182\/blood-2006-08-039024","journal-title":"Blood"},{"key":"4673_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1365-2559.2012.04198.x","volume":"61","author":"C Agostinelli","year":"2012","unstructured":"Agostinelli C, Paterson JC, Gupta R, Righi S, Sandri F, Piccaluga PP et al (2012) Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody. Histopathology 61:33\u201346. https:\/\/doi.org\/10.1111\/j.1365-2559.2012.04198.x","journal-title":"Histopathology"},{"key":"4673_CR40","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3324\/haematol.2017.181024","volume":"103","author":"H Horn","year":"2018","unstructured":"Horn H, Kohler C, Witzig R, Kreuz M, Leich E, Klapper W et al (2018) Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2. Haematologica 103:1182\u20131190. https:\/\/doi.org\/10.3324\/haematol.2017.181024","journal-title":"Haematologica"},{"key":"4673_CR41","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1182\/blood.2024024496","volume":"144","author":"C Laurent","year":"2024","unstructured":"Laurent C, Trisal P, Tesson B, Seth S, Beyou A, Roulland S et al (2024) Follicular lymphoma comprises germinal center-like and memory-like molecular subtypes with prognostic significance. Blood 144:2503\u20132516. https:\/\/doi.org\/10.1182\/blood.2024024496","journal-title":"Blood"},{"key":"4673_CR42","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/PAI.0000000000000107","volume":"23","author":"T Menter","year":"2015","unstructured":"Menter T, Gasser A, Juskevicius D, Dirnhofer S, Tzankov A (2015) Diagnostic Utility of the Germinal Center-associated Markers GCET1, HGAL, and LMO2 in Hematolymphoid Neoplasms. Appl Immunohistochem Mol Morphol 23:491\u2013498. https:\/\/doi.org\/10.1097\/PAI.0000000000000107","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"4673_CR43","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/s0046-8177(99)90003-5","volume":"30","author":"BN Nathwani","year":"1999","unstructured":"Nathwani BN, Anderson JR, Armitage JO, Cavalli F, Diebold J, Drachenberg MR et al (1999) Clinical significance of follicular lymphoma with monocytoid B cells. Non-Hodgkin\u2019s Lymphoma Classification Project. Hum Pathol 30:263\u2013268. https:\/\/doi.org\/10.1016\/s0046-8177(99)90003-5","journal-title":"Hum Pathol"},{"key":"4673_CR44","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/path.1777","volume":"206","author":"E Torlakovic","year":"2005","unstructured":"Torlakovic E, Malecka A, Myklebust JH, Tierens A, Aasheim H-C, Nesland JM et al (2005) PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor. J Pathol 206:312\u2013319. https:\/\/doi.org\/10.1002\/path.1777","journal-title":"J Pathol"},{"key":"4673_CR45","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1309\/EG2M-YHB9-WEFW-7H1R","volume":"118","author":"E Torlakovic","year":"2002","unstructured":"Torlakovic E, Torlakovic G, Brunning RD (2002) Follicular pattern of bone marrow involvement by follicular lymphoma. Am J Clin Pathol 118:780\u2013786. https:\/\/doi.org\/10.1309\/EG2M-YHB9-WEFW-7H1R","journal-title":"Am J Clin Pathol"},{"key":"4673_CR46","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/path.1981","volume":"209","author":"EE Torlakovic","year":"2006","unstructured":"Torlakovic EE, Aamot HV, Heim S (2006) A marginal zone phenotype in follicular lymphoma with t(14;18) is associated with secondary cytogenetic aberrations typical of marginal zone lymphoma. J Pathol 209:258\u2013264. https:\/\/doi.org\/10.1002\/path.1981","journal-title":"J Pathol"},{"key":"4673_CR47","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41379-021-00938-z","volume":"35","author":"SE Gibson","year":"2022","unstructured":"Gibson SE, Liu YC, Yatsenko SA, Barasch NJ, Swerdlow SH (2022) Histopathologic, immunophenotypic, and mutational landscape of follicular lymphomas with plasmacytic differentiation. Mod Pathol 35:60\u201368. https:\/\/doi.org\/10.1038\/s41379-021-00938-z","journal-title":"Mod Pathol"},{"key":"4673_CR48","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1182\/blood-2009-01-198580","volume":"114","author":"E Leich","year":"2009","unstructured":"Leich E, Salaverria I, Bea S, Zettl A, Wright G, Moreno V et al (2009) Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. Blood 114:826\u2013834. https:\/\/doi.org\/10.1182\/blood-2009-01-198580","journal-title":"Blood"},{"key":"4673_CR49","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/10428190701742472","volume":"49","author":"A D\u00edaz-Alderete","year":"2008","unstructured":"D\u00edaz-Alderete A, Doval A, Camacho F, Verde L, Sabin P, Arranz-S\u00e1ez R et al (2008) Frequency of BCL2 and BCL6 translocations in follicular lymphoma: Relation with histological and clinical features. Leuk Lymphoma 49:95\u2013101. https:\/\/doi.org\/10.1080\/10428190701742472","journal-title":"Leuk Lymphoma"},{"key":"4673_CR50","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.humpath.2005.12.005","volume":"37","author":"AG Bosga-Bouwer","year":"2006","unstructured":"Bosga-Bouwer AG, van den Berg A, Haralambieva E, de Jong D, Boonstra R, Kluin P et al (2006) Molecular, cytogenetic, and immunophenotypic characterization of follicular lymphoma grade 3B; a separate entity or part of the spectrum of diffuse large B-cell lymphoma or follicular lymphoma? Hum Pathol 37:528\u2013533. https:\/\/doi.org\/10.1016\/j.humpath.2005.12.005","journal-title":"Hum Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04673-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04673-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04673-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T02:06:09Z","timestamp":1786413969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04673-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":50,"alternative-id":["4673"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04673-1","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None of the authors has any relevant conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}